144 ·Filed May 11, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed4mo ago SEC0001628280-26-033615
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, immaterial insider sale by a director. No trading action warranted. Monitor for any larger insider sales or changes in filing patterns ahead of upcoming earnings or catalysts.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ARQT ▲ +27.74% at T+60d
NEUTRAL call ✓ call won +27.74% · α vs SPY +23.36% · entry $20.69 → $26.43
Entry anchored
May 11, 2026
via day open
T+1d
0.00%
call 0.00% · α -0.54%
$20.69
settled 5mo ago
T+5d
-3.19%
call -3.19% · α -3.27%
$20.03
settled 5mo ago
T+20d
+12.28%
call +12.28% · α +14.00%
$23.23
settled 4mo ago
T+60d
+27.74%
call +27.74% · α +23.36%
$26.43
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Director Patrick Burnett filed a Form 144 notice of intent to sell 222 shares of Arcutis Biotherapeutics (ARQT) worth approximately $4,673, representing a de minimis portion of his holdings. The shares were acquired via restricted stock vesting on May 1, 2026. This is a routine, small-dollar insider sale with no material signal.

Key Facts

  • Insider: Director Patrick Burnett
  • Shares to sell: 222 shares of common stock
  • Approximate value: $4,673
  • Acquisition: Restricted stock vesting on May 1, 2026
  • Broker: Merrill Lynch
  • Filing date: May 11, 2026

Financial Impact

Sale value of ~$4,673 is negligible relative to ARQT's $2.6B market cap (0.00018%)

dilution

Risk Factors

  • No material risk — sale is de minimis and likely part of routine tax or estate planning

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-033615
Document: 0001628280-26-033615-index.html0001628280-26-033615
Document: 0001628280-26-033615.txt0001628280-26-033615
17 reports for ARQT
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +14.74%Mar 2, 2026
Filters
Rows
Reports for ARQT — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.86 $26.38▲ +6.11%▲ +5.87%$25.16 (+1.21%)
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.08 $25.96▲ +3.51%▲ +4.04%$25.16 (+0.32%)
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$25.35 $25.38▲ +0.12%▲ +0.12%$25.16 (−0.75%)
Aug 11, 2026
7w ago
144
NEUTRAL ★ 3/10
$26.28 $23.38▼ −11.04%▼ −9.14%$25.16 (−4.26%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.43 $23.66▼ −10.48%▼ −11.08%$25.16 (−4.81%)
Aug 5, 2026
8w ago
Press Release
BULLISH ★ 7/10
$26.43 $23.66▼ −10.48%▼ −11.08%$25.16 (−4.81%)
Aug 3, 2026
8w ago
144
NEUTRAL ★ 2/10
$26.03 $23.75▼ −8.76%▼ −7.52%$25.16 (−3.34%)
Jun 29, 2026
13w ago
Press Release
BULLISH ★ 7/10
$26.22 $27.84▲ +6.18%▲ +7.21%$25.16 (−4.04%)
Jun 18, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.21 $27.74▲ +5.84%▲ +5.30%$25.16 (−4.01%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$23.23 $28.78▲ +23.89%▲ +20.27%$25.16 (+8.31%)
Showing 10 of 17

US Market Status

Market Closed — Opens Mon (64h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access